TY - JOUR
T1 - The Effect of Bacillus Coagulans and Galactomannans on the Quality of Life of Patients Undergoing Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Clinical Trial
AU - Kazzi, Fay
AU - Daher, Noha
AU - Kray, Genevieve
AU - Zimmerman, Grenith
AU - Scharf, Keith
N1 - Aim/Background The purpose of this study was to examine the effect of probiotics and prebiotics (LactoWise®) on the quality of life (QOL) of morbidly obese patients undergoing laparoscopic sleeve...
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Aim/Background: The purpose of this study was to examine the effect of probiotics and prebiotics (LactoWise®) on the quality of life (QOL) of morbidly obese patients undergoing laparoscopic sleeve gastrectomy (LSG) using the Gastrointestinal Quality of Index (GIQLI). Methods: Study was made of 60 consecutive patients undergoing LSG, who were randomized into two groups, one of which took LactoWise® and the other a placebo. The LactoWise® group received 4.5 billion live cells of Bacillus coagulans and galactomannans (300 mg) in capsule form, and the placebo group received 600 mg of calcium citrate yielding 126 mg of elemental calcium, in identical capsules, daily for 3 months post-surgery. The participants completed the GIQLI prior to surgery at their pre-operation consultation and 3 times post-surgery, at 2 and 6 weeks and at 3 months. Results: A total of 40 patients, with a mean age of 48.0±12.7 years and body mass index (BMI) of 46.2 ±8.0 kg/m 2 completed the study. In both the group taking LactoWise® and the placebo group, following surgery a significant improvement in QOL, according to the median scores on GIQLI was recorded over time (p
AB - Aim/Background: The purpose of this study was to examine the effect of probiotics and prebiotics (LactoWise®) on the quality of life (QOL) of morbidly obese patients undergoing laparoscopic sleeve gastrectomy (LSG) using the Gastrointestinal Quality of Index (GIQLI). Methods: Study was made of 60 consecutive patients undergoing LSG, who were randomized into two groups, one of which took LactoWise® and the other a placebo. The LactoWise® group received 4.5 billion live cells of Bacillus coagulans and galactomannans (300 mg) in capsule form, and the placebo group received 600 mg of calcium citrate yielding 126 mg of elemental calcium, in identical capsules, daily for 3 months post-surgery. The participants completed the GIQLI prior to surgery at their pre-operation consultation and 3 times post-surgery, at 2 and 6 weeks and at 3 months. Results: A total of 40 patients, with a mean age of 48.0±12.7 years and body mass index (BMI) of 46.2 ±8.0 kg/m 2 completed the study. In both the group taking LactoWise® and the placebo group, following surgery a significant improvement in QOL, according to the median scores on GIQLI was recorded over time (p
UR - https://link.springer.com/article/10.1007%2Fs13126-018-0456-0
UR - https://www.mendeley.com/catalogue/eb3f5cb6-3edd-3395-8f1c-71887674ba23/
U2 - 10.1007/s13126-018-0456-0
DO - 10.1007/s13126-018-0456-0
M3 - Article
VL - 90
SP - 121
EP - 126
JO - Hellenic Journal of Surgery
JF - Hellenic Journal of Surgery
ER -